Laga assists national and international investors syndicate with Series A Financing Round
Taking on your challenges
14 April 2016
Laga assisted an investors’ syndicate of national and international investors (LSP V COÖPERATIEVE U.A, BOEHRINGER INGELHEIM VENTURE FUND GMBH, PARTICIPATIEMAATSCHAPPIJ VLAANDEREN NV, OMEGA FUND V, L.P. and FUND+ NV) in connection with the negotiation and implementation of a EUR 24 million Series A Financing Round in eTheRNA NV.
eTheRNA immunotherapies is a spin-off from the Brussels University 'Vrije Universiteit Brussel' (VUB). This investment will enable the company to continue the development of its innovative immunotherapies to treat melanoma, breast cancer and infectious diseases.